Concepts (127)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Catheter Ablation | 2 | 2006 | 229 | 0.450 |
Why?
|
| Lung Neoplasms | 2 | 2006 | 1173 | 0.290 |
Why?
|
| Cancer Vaccines | 2 | 2004 | 61 | 0.270 |
Why?
|
| Thymoma | 1 | 2003 | 14 | 0.220 |
Why?
|
| Thymus Neoplasms | 1 | 2003 | 17 | 0.220 |
Why?
|
| Interleukin-2 | 1 | 2003 | 133 | 0.210 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2005 | 300 | 0.210 |
Why?
|
| Eosinophils | 2 | 2018 | 60 | 0.200 |
Why?
|
| T-Lymphocytes | 1 | 2003 | 597 | 0.170 |
Why?
|
| Surgical Sponges | 1 | 2019 | 5 | 0.170 |
Why?
|
| Blood Transfusion, Autologous | 1 | 2019 | 17 | 0.170 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 2018 | 6 | 0.160 |
Why?
|
| Blood Loss, Surgical | 1 | 2019 | 79 | 0.160 |
Why?
|
| Lectins | 1 | 2018 | 81 | 0.160 |
Why?
|
| Allergens | 1 | 2018 | 54 | 0.150 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2018 | 117 | 0.150 |
Why?
|
| Pancreatic Polypeptide-Secreting Cells | 1 | 2017 | 1 | 0.150 |
Why?
|
| Duodenum | 1 | 2017 | 47 | 0.150 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2018 | 144 | 0.150 |
Why?
|
| Antigens, CD | 1 | 2018 | 230 | 0.150 |
Why?
|
| Liraglutide | 1 | 2017 | 18 | 0.150 |
Why?
|
| Cell Adhesion Molecules | 1 | 2018 | 199 | 0.150 |
Why?
|
| Pancreas | 1 | 2017 | 225 | 0.130 |
Why?
|
| Transforming Growth Factor beta | 1 | 2018 | 384 | 0.130 |
Why?
|
| Gene Expression | 1 | 2018 | 770 | 0.130 |
Why?
|
| Lymphoscintigraphy | 1 | 2015 | 5 | 0.130 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2015 | 53 | 0.120 |
Why?
|
| Adenocarcinoma | 1 | 2017 | 475 | 0.120 |
Why?
|
| Hypoglycemic Agents | 1 | 2017 | 362 | 0.120 |
Why?
|
| Pancreatic Neoplasms | 1 | 2017 | 332 | 0.110 |
Why?
|
| Lung | 1 | 2018 | 849 | 0.110 |
Why?
|
| Preoperative Care | 1 | 2015 | 275 | 0.110 |
Why?
|
| Cell Proliferation | 1 | 2017 | 1174 | 0.110 |
Why?
|
| Equipment Design | 2 | 2019 | 500 | 0.100 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2004 | 266 | 0.100 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2018 | 101 | 0.090 |
Why?
|
| Flow Cytometry | 2 | 2018 | 489 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2017 | 1085 | 0.080 |
Why?
|
| Sarcoma, Experimental | 1 | 2006 | 5 | 0.070 |
Why?
|
| Animals | 6 | 2019 | 20881 | 0.070 |
Why?
|
| Mice, Transgenic | 3 | 2004 | 1033 | 0.070 |
Why?
|
| Sus scrofa | 1 | 2006 | 74 | 0.070 |
Why?
|
| Pneumothorax | 1 | 2006 | 42 | 0.070 |
Why?
|
| Electrodes | 1 | 2006 | 147 | 0.070 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2004 | 126 | 0.070 |
Why?
|
| Rabbits | 1 | 2006 | 509 | 0.060 |
Why?
|
| Disease-Free Survival | 1 | 2006 | 349 | 0.060 |
Why?
|
| Breast Neoplasms | 1 | 2015 | 1536 | 0.060 |
Why?
|
| Positron-Emission Tomography | 1 | 2006 | 160 | 0.060 |
Why?
|
| Lymph Node Excision | 1 | 2005 | 91 | 0.060 |
Why?
|
| Pneumonectomy | 1 | 2005 | 79 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2006 | 714 | 0.060 |
Why?
|
| Vaccines, Subunit | 1 | 2004 | 10 | 0.060 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2004 | 38 | 0.060 |
Why?
|
| Adjuvants, Immunologic | 1 | 2004 | 63 | 0.060 |
Why?
|
| Interleukin-12 | 1 | 2004 | 75 | 0.060 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2003 | 29 | 0.050 |
Why?
|
| Interferon-gamma | 1 | 2004 | 241 | 0.050 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2003 | 66 | 0.050 |
Why?
|
| Transduction, Genetic | 1 | 2003 | 81 | 0.050 |
Why?
|
| Disease Progression | 1 | 2006 | 1038 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 3 | 2004 | 2791 | 0.050 |
Why?
|
| Spleen | 1 | 2003 | 301 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2003 | 135 | 0.050 |
Why?
|
| Patient Selection | 1 | 2006 | 592 | 0.050 |
Why?
|
| Cell Division | 1 | 2003 | 541 | 0.050 |
Why?
|
| Lymph Nodes | 1 | 2003 | 258 | 0.050 |
Why?
|
| Humans | 7 | 2019 | 68618 | 0.050 |
Why?
|
| Lymphocyte Activation | 1 | 2003 | 397 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2005 | 1342 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 742 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2017 | 7029 | 0.050 |
Why?
|
| Cell Migration Assays, Leukocyte | 1 | 2018 | 1 | 0.040 |
Why?
|
| Interleukin-5 | 1 | 2018 | 14 | 0.040 |
Why?
|
| Erythrocytes | 1 | 2019 | 137 | 0.040 |
Why?
|
| Ambrosia | 1 | 2018 | 1 | 0.040 |
Why?
|
| Pyroglyphidae | 1 | 2018 | 2 | 0.040 |
Why?
|
| Interleukin-3 | 1 | 2018 | 63 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2006 | 1615 | 0.040 |
Why?
|
| Blood Cells | 1 | 2018 | 27 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 2018 | 110 | 0.040 |
Why?
|
| Basophils | 1 | 2018 | 57 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2005 | 3705 | 0.040 |
Why?
|
| Time Factors | 2 | 2017 | 4655 | 0.040 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2017 | 34 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 1 | 2018 | 261 | 0.040 |
Why?
|
| Hyperplasia | 1 | 2017 | 89 | 0.040 |
Why?
|
| Cell Adhesion | 1 | 2018 | 324 | 0.040 |
Why?
|
| Mice | 3 | 2004 | 8474 | 0.040 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2017 | 129 | 0.040 |
Why?
|
| Swine | 1 | 2019 | 672 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2017 | 164 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2006 | 2324 | 0.030 |
Why?
|
| Aged | 2 | 2017 | 14862 | 0.030 |
Why?
|
| Apoptosis | 1 | 2003 | 1641 | 0.030 |
Why?
|
| Cell Survival | 1 | 2019 | 901 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2018 | 370 | 0.030 |
Why?
|
| Cell Movement | 1 | 2018 | 630 | 0.030 |
Why?
|
| Axilla | 1 | 2015 | 36 | 0.030 |
Why?
|
| Male | 3 | 2018 | 37321 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 1174 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2015 | 274 | 0.030 |
Why?
|
| Asthma | 1 | 2018 | 345 | 0.030 |
Why?
|
| Egg Proteins | 2 | 2004 | 15 | 0.030 |
Why?
|
| Ovalbumin | 2 | 2004 | 33 | 0.030 |
Why?
|
| Middle Aged | 2 | 2015 | 21147 | 0.030 |
Why?
|
| Biomarkers | 1 | 2018 | 1593 | 0.030 |
Why?
|
| Peptide Fragments | 2 | 2004 | 483 | 0.020 |
Why?
|
| Female | 2 | 2015 | 38074 | 0.020 |
Why?
|
| Risk Factors | 1 | 2017 | 5731 | 0.020 |
Why?
|
| Receptors, Interleukin-12 | 1 | 2004 | 4 | 0.010 |
Why?
|
| Receptors, Interleukin | 1 | 2004 | 22 | 0.010 |
Why?
|
| Paracrine Communication | 1 | 2004 | 31 | 0.010 |
Why?
|
| Gels | 1 | 2004 | 55 | 0.010 |
Why?
|
| Antigen-Presenting Cells | 1 | 2004 | 50 | 0.010 |
Why?
|
| Immunologic Memory | 1 | 2004 | 75 | 0.010 |
Why?
|
| Adoptive Transfer | 1 | 2004 | 100 | 0.010 |
Why?
|
| Melanoma, Experimental | 1 | 2004 | 95 | 0.010 |
Why?
|
| Genes, T-Cell Receptor alpha | 1 | 2003 | 3 | 0.010 |
Why?
|
| Moloney murine leukemia virus | 1 | 2003 | 13 | 0.010 |
Why?
|
| Genes, T-Cell Receptor beta | 1 | 2003 | 5 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2015 | 7277 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2003 | 312 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2003 | 852 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 1851 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2003 | 1034 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2003 | 2673 | 0.010 |
Why?
|